Neuroleptic Responsiveness in Siblings Concordant for Schizophrenia
| Autor: | L E, DeLisi, D, Dauphinais |
|---|---|
| Rok vydání: | 1989 |
| Předmět: |
medicine.medical_specialty
Treatment response medicine.diagnostic_test medicine.medical_treatment Genetic vulnerability Retrospective cohort study Physical examination Lithium medicine.disease Psychiatry and Mental health Basal Ganglia Diseases Arts and Humanities (miscellaneous) Schizophrenia medicine Humans Antipsychotic Psychiatry Psychology Basal ganglia disease Antipsychotic Agents Retrospective Studies Clinical psychology |
| Zdroj: | Archives of General Psychiatry. 46:477 |
| ISSN: | 0003-990X |
| DOI: | 10.1001/archpsyc.1989.01810050091014 |
| Popis: | To the Editor.— Recently we reported the results of a clinical examination of siblings who were concordant for schizophrenia. 1 We have received queries from several interested colleagues as to whether, in addition to the clinical characteristics we noted, we also were able to detect whether pharmacologic response to antipsychotic medication was similar within families. The interest in this issue is twofold: (1) response to neuroleptics is known to have a strong genetic basis, and thus could be hypothesized to be related to the genetics of schizophrenia; and (2) faced with the potential heterogeneity of the cause of schizophrenia, division of subjects by pharmacologic responsiveness to define specific biologic entities could be a valid method of classification. Siblings concordant for schizophrenia could be examined to test these hypotheses based on the assumption that within each family schizophrenic illness will have the same cause, genetic vulnerability, and pathogenesis. Treatment response, however |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|